WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Authors
Gourley, CharliePaige, Adam J.W.
Taylor, Karen J.
Ward, Carol
Kuske, Barbara
Zhang, Jieqing
Sun, Mingjun
Janczar, Szymon
Harrison, David J.
Muir, Morwenna
Smyth, John F.
Gabra, Hani
Affiliation
University of Edinburgh Cancer Research CentreIssue Date
2009-06-01
Metadata
Show full item recordAbstract
The WW domain-containing oxidoreductase (WWOX) gene is located at FRA16D, a common fragile site involved in human cancer. Targeted deletion of Wwox in mice causes increased spontaneous tumor incidence, confirming that WWOX is a bona fide tumor suppressor gene. We show that stable transfection of WWOX into human PEO1 ovarian cancer cells, containing homozygous WWOX deletion, abolishes in vivo tumorigenicity, but this does not correlate with alteration of in vitro growth. Rather, WWOX restoration in PEO1, or WWOX overexpression in SKOV3 ovarian cancer cells, results in reduced attachment and migration on fibronectin, an extracellular matrix component linked to peritoneal metastasis. Conversely, siRNA-mediated knockdown of endogenous WWOX in A2780 ovarian cancer cells increases adhesion to fibronectin. In addition, whereas there is no WWOX-dependent difference in cell death in adherent cells, WWOX-transfected cells in suspension culture display a proapoptotic phenotype. We further show that WWOX expression reduces membranous integrin alpha(3) protein but not integrin alpha(3) mRNA levels, and that adhesion of PEO1 cells to fibronectin is predominantly mediated through integrin alpha(3). We therefore propose that WWOX acts as an ovarian tumor suppressor by modulating the interaction between tumor cells and the extracellular matrix and by inducing apoptosis in detached cells. Consistent with this, the suppression of PEO1 tumorigenicity by WWOX can be partially overcome by implanting these tumor cells in Matrigel. These data suggest a possible role for the loss of WWOX in the peritoneal dissemination of human ovarian cancer cells.Citation
Gourley, C. et al (2009) 'WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3' Cancer Res. 69 (11):4835-4842Publisher
American Association for Cancer ResearchJournal
Cancer researchPubMed ID
19458077Additional Links
http://www.ncbi.nlm.nih.gov/pubmed/19458077http://cancerres.aacrjournals.org/content/69/11/4835.long
Type
ArticleLanguage
enISSN
1538-7445ae974a485f413a2113503eed53cd6c53
10.1158/0008-5472.CAN-08-2974
Scopus Count
Collections
Related articles
- [Effects of WWOX on ovarian cancer cell attachment in vitro].
- Authors: Zhang JQ, Li L, Song HL, Adam P, Hani G
- Issue date: 2009 Jun
- [Effect of WWOX gene on the attachment and adhesion of ovarian cancer cells].
- Authors: Zhang JQ, Li L, Song HL, Paige A, Gabra H
- Issue date: 2009 Jul
- Reversing effect of exogenous WWOX gene expression on malignant phenotype of primary cultured lung carcinoma cells.
- Authors: Zhou YL, Li YC, Shou F, Liu CQ, Pu Y, Tang H
- Issue date: 2010 Mar 5
- Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
- Authors: Furuya M, Kato H, Nishimura N, Ishiwata I, Ikeda H, Ito R, Yoshiki T, Ishikura H
- Issue date: 2005 Apr 1
- WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.
- Authors: Paige AJ, Zucknick M, Janczar S, Paul J, Mein CA, Taylor KJ, Stewart M, Gourley C, Richardson S, Perren T, Ganesan TS, Smyth JF, Brown R, Gabra H
- Issue date: 2010 Mar